385 related articles for article (PubMed ID: 1378313)
1. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
2. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
3. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor (FGF-2) internalization through the heparan sulfate proteoglycans-mediated pathway: an ultrastructural approach.
Gleizes PE; Noaillac-Depeyre J; Amalric F; Gas N
Eur J Cell Biol; 1995 Jan; 66(1):47-59. PubMed ID: 7750519
[TBL] [Abstract][Full Text] [Related]
6. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
Forsten-Williams K; Chua CC; Nugent MA
J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
10. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
[TBL] [Abstract][Full Text] [Related]
11. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
Delehedde M; Deudon E; Boilly B; Hondermarck H
Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
[TBL] [Abstract][Full Text] [Related]
13. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
14. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor.
Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK
Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
Presta M; Maier JA; Rusnati M; Ragnotti G
J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor.
Gordon PB; Choi HU; Conn G; Ahmed A; Ehrmann B; Rosenberg L; Hatcher VB
J Cell Physiol; 1989 Sep; 140(3):584-92. PubMed ID: 2528552
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells.
Sperinde GV; Nugent MA
Biochemistry; 1998 Sep; 37(38):13153-64. PubMed ID: 9748322
[TBL] [Abstract][Full Text] [Related]
18. Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1995 Jan; 316(1):227-34. PubMed ID: 7840621
[TBL] [Abstract][Full Text] [Related]
19. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms for the regulation of growth factor binding by heparin.
Forsten KE; Fannon M; Nugent MA
J Theor Biol; 2000 Jul; 205(2):215-30. PubMed ID: 10873433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
